Screener/Healthcare/Biotechnology

KYMR

Kymera Therapeutics, Inc.NASDAQ
$74.37-2.62 (-3.40%)
Mid CapHealthcareHigh Beta
$19.45
$103.00
$73.31
$76.01
EPS (TTM)$-3.69
P/E Ratio—
Dividend Yield—
Market Cap$6.50B
Volume312K
Prev Close$76.96
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q4 '25$2.9M-$87.0M$-0.980.0%-3030.7%
Q3 '25$2.8M-$82.2M$-0.940.0%-2973.0%
Q2 '25$11.5M-$76.6M$-0.950.0%-667.6%
Q1 '25$22.1M-$65.6M$-0.820.0%-296.7%
Q4 '24$7.4M-$70.8M$-0.89—-956.9%
Q3 '24$3.7M-$62.5M$-0.82—-1670.3%
Q2 '24$25.6M-$42.1M$-0.58—-164.0%
Q1 '24$10.3M-$48.6M$-0.69—-472.0%
Get Your Daily Market Recap